Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $28,687,000 | $13,969,000 | $16,113,000 | $12,956,000 |
| Dep. & Amort. | $6,335,000 | $5,172,000 | $4,952,000 | $4,321,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$6,330,000 | -$1,227,000 | -$262,000 | $4,291,000 |
| Other Non-Cash | -$9,927,000 | $274,000 | -$8,076,000 | -$2,369,000 |
| Operating Cash Flow | $18,765,000 | $18,188,000 | $12,727,000 | $19,199,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,627,000 | -$12,924,000 | -$7,908,000 | -$4,193,000 |
| Net Acquisitions | $0 | -$6,800,000 | $957,000 | -$544,000 |
| Inv. Purchases | -$511,000 | -$15,000 | -$5,897,000 | -$340,000 |
| Inv. Sales/Matur. | $8,135,000 | $1,552,000 | $1,999,000 | $2,440,000 |
| Other Inv. Act. | $23,566,000 | $15,675,000 | -$13,019,000 | -$10,423,000 |
| Investing Cash Flow | $17,563,000 | -$2,512,000 | -$23,868,000 | -$13,060,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,613,000 | -$70,000 | -$71,000 | -$117,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$10,554,000 | -$9,796,000 | -$7,694,000 | -$8,043,000 |
| Dividends Paid | -$6,519,000 | -$6,578,000 | -$6,719,000 | -$6,839,000 |
| Other Fin. Act. | -$390,000 | -$247,000 | -$203,000 | -$190,000 |
| Financing Cash Flow | -$15,850,000 | -$16,691,000 | -$14,687,000 | -$15,189,000 |
| Forex Effect | $2,936,000 | $1,957,000 | $5,005,000 | $3,944,000 |
| Net Chg. in Cash | $23,414,000 | $942,000 | -$20,823,000 | -$5,107,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $66,366,000 | $65,424,000 | $86,247,000 | $91,354,000 |
| End Cash | $89,780,000 | $66,366,000 | $65,424,000 | $86,247,000 |
| Free Cash Flow | $4,991,000 | $5,152,000 | $4,819,000 | $15,006,000 |